您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Ezetimibe
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Ezetimibe
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Ezetimibe图片
CAS NO:163222-33-1
包装与价格:
包装价格(元)
5 mg电议
10 mg电议
50 mg电议
100 mg电议
200 mg电议
500 mg电议
1 mL*10 mM(in DMSO)电议

产品名称
依泽替米贝
SCH 58235
产品介绍
Ezetimibe 是一种膳食胆固醇吸收抑制剂。它是一种NPC1L1抑制剂,是有效的Nrf2激活剂。

产品描述

Ezetimibe is a Dietary Cholesterol Absorption Inhibitor. The physiologic effect of ezetimibe is by means of Decreased Cholesterol Absorption.

体外活性

有效地抑制胆固醇穿过肠壁的转运,从而降低高胆固醇血症的临床前动物模型中的血浆胆固醇.Ezetimibe消除大鼠肠道的胰腺外分泌功能,同时保持胆汁流量.Ezetimibe降低胆固醇喂养的仓鼠的血浆胆固醇和肝胆固醇积累,ED(50)为0.04 mg/kg.Ezetimibe减少主动脉粥样硬化病变的表面积,从对照组的20.2%到西方饮食组的4.1%和低脂肪胆固醇饮食小鼠的7.0%.Ezetimibe减少颈动脉粥样硬化病变的横截面面积,在西方低脂胆固醇饮食组中为97%,在无胆固醇的小鼠中为91%.

体内活性

Ezetimibe显著降低表面受体SR-BI,Niemann-Pick C1型类似蛋白1,ATP结合盒转运子,亚族A和核受体维甲酸受体的γ,固醇调节元件结合蛋白-1和-2,肝X受体的β亚基的mRNA的表达。Ezetimibe明显降低总胆固醇,LDL胆固醇和甘油三酸酯,适度增加高密度脂蛋白胆固醇。 Ezetimibe在Caco-2细胞中,将胆固醇转运减少了31%,但不影响黄醇转运。

激酶实验

GST-p62 is prepared from Escherichia coli and 0.5 μg of the purified GST-p62 protein is used for in vitro AMPK phosphorylation assay. Phosphorylation of p62 protein by AMPK is determined by non-radioisotope method using γS-ATP. AMPK complex is immuno-purified from the HEK293 cells, to which either myc-AMPKα1 wild-type (WT) or myc-AMPKα1 kinase-dead mutant (KD, D157A) is transfected with Flag-AMPKβ1 and HA-AMPKγ1. AMPK complex is added into the reaction mixture containing 20 mM HEPES, pH7.4, 1 mM EGTA, 0.4 mM EDTA, 5 mM MgCl2, 0.05 mM DTT, 0.5 μg GST-p62, 0.2 mM AMP, and 1 mM ATPγS. Reaction is carried out at 37°C for 30 min, and then terminated by adding 20 mM EDTA. To detect γS-labeled p62 protein, the reaction product is alkylated with 2.5 mM PNBM for 2 h at room temperature and analyzed the products by western blotting using anti-thiophosphate antibody[1].

细胞实验

Ezetimibe is dissolved in DMSO and stored, and then diluted with appropriate medium before use[2]. Huh7 human hepatocytes are cultured in high glucose DMEM containing 10% FBS, 100 units/mL penicillin and 100 μg/mL streptomycin at 37°C in a 95% air/5% CO2 atmosphere. Hepatocytes are treated with or without Ezetimibe (10 μM, 1 h) and incubated with palmitic acid (PA, 0.5 mM, 24 h)[2].

Cas No.

163222-33-1

分子式

C24H21F2NO3

分子量

409.43

别名

依泽替米贝;SCH 58235

储存和溶解度

H2O:<1 mgml
Ethanol:75 mg/mL (183.2 mM)
DMSO:75 mg/mL (183.2 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years